154 related articles for article (PubMed ID: 30816914)
21. TWEAK favors phosphate-induced calcification of vascular smooth muscle cells through canonical and non-canonical activation of NFκB.
Hénaut L; Sanz AB; Martin-Sanchez D; Carrasco S; Villa-Bellosta R; Aldamiz-Echevarria G; Massy ZA; Sanchez-Nino MD; Ortiz A
Cell Death Dis; 2016 Jul; 7(7):e2305. PubMed ID: 27441657
[TBL] [Abstract][Full Text] [Related]
22. Studies on the interaction between TWEAK and the death receptor WSL-1/TRAMP (DR3).
Kaptein A; Jansen M; Dilaver G; Kitson J; Dash L; Wang E; Owen MJ; Bodmer JL; Tschopp J; Farrow SN
FEBS Lett; 2000 Nov; 485(2-3):135-41. PubMed ID: 11094155
[TBL] [Abstract][Full Text] [Related]
23. [Atorvastatin inhibits the atherosclerotic lesion induced by tumor necrosis factor-like weak inducer of apoptosis in apolipoprotein E deficient mice].
Fernández-Laso V; Sastre C; Egido J; Martín-Ventura JL; Blanco-Colio LM
Clin Investig Arterioscler; 2015; 27(1):17-25. PubMed ID: 25027757
[TBL] [Abstract][Full Text] [Related]
24. Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Mönckeberg's sclerosis and atherosclerosis.
Schoppet M; Al-Fakhri N; Franke FE; Katz N; Barth PJ; Maisch B; Preissner KT; Hofbauer LC
J Clin Endocrinol Metab; 2004 Aug; 89(8):4104-12. PubMed ID: 15292354
[TBL] [Abstract][Full Text] [Related]
25. TWEAK/Fn14 promotes pro-inflammatory cytokine secretion in hepatic stellate cells via NF-κB/STAT3 pathways.
Wang A; Zhang F; Xu H; Xu M; Cao Y; Wang C; Xu Y; Su M; Zhang M; Zhuge Y
Mol Immunol; 2017 Jul; 87():67-75. PubMed ID: 28411440
[TBL] [Abstract][Full Text] [Related]
26. Pathological activation of canonical nuclear-factor κB by synergy of tumor necrosis factor α and TNF-like weak inducer of apoptosis in mouse acute colitis.
Dohi T; Kawashima R; Kawamura YI; Otsubo T; Hagiwara T; Amatucci A; Michaelson J; Burkly LC
Cytokine; 2014 Sep; 69(1):14-21. PubMed ID: 25022957
[TBL] [Abstract][Full Text] [Related]
27. The tumour necrosis factor superfamily ligand APRIL (TNFSF13) is released upon platelet activation and expressed in atherosclerosis.
Sandberg WJ; Otterdal K; Gullestad L; Halvorsen B; Ragnarsson A; Frøland SS; Damås JK; Oie E; Aukrust P; Hansson GK; Yndestad A
Thromb Haemost; 2009 Oct; 102(4):704-10. PubMed ID: 19806256
[TBL] [Abstract][Full Text] [Related]
28. Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failure.
Yndestad A; Damås JK; Geir Eiken H; Holm T; Haug T; Simonsen S; Frøland SS; Gullestad L; Aukrust P
Cardiovasc Res; 2002 Apr; 54(1):175-82. PubMed ID: 12062373
[TBL] [Abstract][Full Text] [Related]
29. Multiple members of the TNF superfamily contribute to IFN-gamma-mediated inhibition of erythropoiesis.
Felli N; Pedini F; Zeuner A; Petrucci E; Testa U; Conticello C; Biffoni M; Di Cataldo A; Winkles JA; Peschle C; De Maria R
J Immunol; 2005 Aug; 175(3):1464-72. PubMed ID: 16034083
[TBL] [Abstract][Full Text] [Related]
30. Regulation of cell fate by lymphotoxin (LT) receptor signalling: Functional differences and similarities of the LT system to other TNF superfamily (TNFSF) members.
Albarbar B; Dunnill C; Georgopoulos NT
Cytokine Growth Factor Rev; 2015 Dec; 26(6):659-71. PubMed ID: 26028499
[TBL] [Abstract][Full Text] [Related]
31. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
Song JH; Bellail A; Tse MC; Yong VW; Hao C
J Neurosci; 2006 Mar; 26(12):3299-308. PubMed ID: 16554480
[TBL] [Abstract][Full Text] [Related]
32. HMGB1 expression and secretion are increased via TWEAK-Fn14 interaction in atherosclerotic plaques and cultured monocytes.
Moreno JA; Sastre C; Madrigal-Matute J; Muñoz-García B; Ortega L; Burkly LC; Egido J; Martín-Ventura JL; Blanco-Colio LM
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):612-20. PubMed ID: 23288170
[TBL] [Abstract][Full Text] [Related]
33. Molecular, structural, and biological characteristics of the tumor necrosis factor ligand superfamily.
Gruss HJ
Int J Clin Lab Res; 1996; 26(3):143-59. PubMed ID: 8905447
[TBL] [Abstract][Full Text] [Related]
34. A family of ligands for the TNF receptor superfamily.
Cosman D
Stem Cells; 1994 Sep; 12(5):440-55. PubMed ID: 7528588
[TBL] [Abstract][Full Text] [Related]
35. TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor.
Wiley SR; Winkles JA
Cytokine Growth Factor Rev; 2003; 14(3-4):241-9. PubMed ID: 12787562
[TBL] [Abstract][Full Text] [Related]
36. TWEAK and Fn14: new molecular targets for cancer therapy?
Winkles JA; Tran NL; Berens ME
Cancer Lett; 2006 Apr; 235(1):11-7. PubMed ID: 15885893
[TBL] [Abstract][Full Text] [Related]
37. Tumor necrosis factor superfamily in innate immunity and inflammation.
Šedý J; Bekiaris V; Ware CF
Cold Spring Harb Perspect Biol; 2014 Dec; 7(4):a016279. PubMed ID: 25524549
[TBL] [Abstract][Full Text] [Related]
38. Structural and biological features of the TNF receptor and TNF ligand superfamilies: interactive signals in the pathobiology of Hodgkin's disease.
Gruss HJ; Duyster J; Herrmann F
Ann Oncol; 1996; 7 Suppl 4():19-26. PubMed ID: 8836404
[TBL] [Abstract][Full Text] [Related]
39. Workshop summary: cell death mechanisms controlled by the TNF family.
Eriksson JE; Vandenabeele P
Adv Exp Med Biol; 2011; 691():585-8. PubMed ID: 21153364
[No Abstract] [Full Text] [Related]
40. Proinflammatory effects of tumour necrosis factor-like weak inducer of apoptosis (TWEAK) on human gingival fibroblasts.
Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
Clin Exp Immunol; 2006 Dec; 146(3):540-9. PubMed ID: 17100776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
